Flowers

Red Clover

Trifolium pratense
Also known as: —
Specimen 079 50.0°N, 10.0°E
Europe & Western Asia
Catalogued: Entry 79 of 110
Menopause Hot Flashes
EVIDENCE STRENGTH: LIMITED–MODERATE
Meta-analyses lean modestly positive, but individual trials genuinely disagree, plus real funding-bias concerns
Region
Europe and Western Asia
Source
Flowers of the Trifolium pratense plant
Plant family
Fabaceae (the legume family)
First recorded use
European and North American Indigenous folk medicine

Where the meta-analyses and the trials disagree

Red clover has a long history as a European folk medicine plant, and later became adopted into North American herbal traditions, including use by the Cherokee. It gained particular prominence in 19th-century Western herbalism as a general "blood purifier" and women's health remedy, a use that has narrowed considerably in modern research toward one specific application: menopausal symptom relief.

Red clover's modern reputation rests almost entirely on its isoflavone content — plant compounds structurally similar to estrogen — positioning it as a phytoestrogen alternative to hormone replacement therapy.

EVIDENCE STRENGTH: LIMITED–MODERATE

What clinical research actually shows

Red clover has a genuinely mixed evidence picture, with meta-analyses leaning modestly positive while individual trials remain notably inconsistent. A recent GRADE-assessed meta-analysis of 9 randomized controlled trials found a statistically significant, small-to-moderate reduction in hot flash frequency compared to placebo. An earlier meta-analysis of 8 trials similarly found a significant reduction, with the strongest effects at doses of 80mg or more of isoflavones daily over at least 12 weeks.

The genuine complication: individual large trials disagree meaningfully. The well-known Isoflavone Clover Extract (ICE) study, involving 252 women, found no significant difference between red clover and placebo. A 2014 review described the overall evidence as "insufficient" and "inconclusive," and separately noted that over half of published red clover trials were at least partially funded by product manufacturers. Europe's food safety authority has found no adequate evidence supporting isoflavone claims for menopausal symptoms. "Limited-Moderate" is the honest, balanced rating.

Sources

  • The effectiveness of red clover on hot-flash in menopausal women: a GRADE-assessed systematic review and meta-analysis — ScienceDirect (2026), 9 RCTs
  • Evaluation of Clinical Meaningfulness of Red Clover Extract to Relieve Hot Flushes: Systematic Review and Meta-Analysis — PMC, 8 trials
  • Van de Weijer et al., Phytoestrogen supplements for hot flashes: the ICE Study — JAMA (2003), 252 women, no significant benefit
  • Red clover extract for alleviating hot flushes in postmenopausal women: A meta-analysis — ScienceDirect (2014)

Dried flowers, or standardized extract

Flowers dried and steeped as tea; modern research uses standardized isoflavone extracts (commonly branded as Promensil or similar).

Modern forms and who should be cautious

💊 Common modern forms

  • Standardized isoflavone extract capsules/tablets
  • Tea

⚠️ Who should be cautious

  • People with hormone-sensitive conditions (breast cancer, uterine fibroids, endometriosis) should avoid red clover given its estrogenic activity, and discuss with a doctor first
  • Those on blood-thinning medication should be cautious given red clover's mild anticoagulant properties

🚨 When to see a doctor instead

  • Significant menopausal symptoms affecting quality of life deserve a conversation with a doctor about the full range of evidence-based options, including hormone therapy, which has notably stronger evidence for symptom severity
EPISODE 79 · RED CLOVER, WHERE THE META-ANALYSES AND THE TRIALS DISAGREE

Related specimens

This entry is educational and historical, not medical advice. Always consult a licensed healthcare professional before trying a new remedy. Read our full disclaimer →